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Abstract 
Backgrounds: Cigarette smoke contains a large number of chemical substances with 
hepatotoxic potential including nicotine. Many researchers have reported that, the 
relationship between cigarette smoker and liver injury.  
Objectives: The objective of this study was to investigate the serum liver function tests 
among Sudanese adult cigarette smokers.  
Methods: This study was an analytical case control study, carried out in Omdurman 
city, 100 subjects enrolled in the study matched for age and sex, 50 cigarette smokers 
as case group, with their age ranged between 18 to 43 years and the mean age was 24 
years, and also 50 non smokers as control group, all study parameters estimated using 
spectrophotometric methods.  
Results: The (mean ± SD) serum total proteins, albumin, total bilirubin, AST, ALT and 
ALP levels in cigarette smokers and non smokers respectively were (6.63±9.14g/L, 
3.37±4.11g/L, 0.66±0.15mg/dL, 26.66±8.46 IU/L, 19.00±8.89 IU/L, 157.84±17.43 
IU/L), (6.90±6.21g/L, 3.45±2.78g/L, 0.55±0.16 15mg/dL, 23.50±4.95 IU/L, 
13.91±5.33 IU/L, 146.67±11.52 IU/L). There was statistically significant difference 
(P<0.05) between serum ALP, ALT and total bilirubin levels between smokers and 
control subjects. The age had a positive correlation with serum bilirubin, serum ALT 
and serum ALP respectively (r=0.387, p=0.006, r=0.393, P=0.005, r=0.0318, p=0.025).  
Conclusion: Cigarette smokers had a significant increase in serum ALP, ALT and total 
bilirubin levels. This study also revealed a positive correlation between age and serum 
total bilirubin, ALT and ALP. 
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                                                                                                                      المستخلص
: يحتوي دخان السجائر على عدد كبير من المواد الكيميائية الضارة للكبد مثل مركب النيكوتين, و قد أورد الخلفية
: كان هدف هذه الدراسة هو أهداف البحثعدد من الباحثين بأن هنالك علاقة واضحة بين التدخين و أمراض الكبد. 
يلية :  كانت هذه الدراسة دراسة تحلالطرق المتبعةالسجائر السودانيين البالغين.  فحص وظائف الكبد في دم مدخني
متطوع متوافقين في العمر و  001وصفية محكمة للحالات المرضية, أجريت في مدينة أمدرمان؛ و احتوت على 
سنة،  42سنة وبمتوسط عمر  34و  81منهم مدخنين كمجموعة حالة للبحث تتراوح أعمارهم بين  05الجنس، 
منهم كانوا غير مدخنين كمجموعة تحكم للبحث. كل فحوصات البحث قد أجريت باستخدام قياس الطيف  05بينما 
الانحراف المعياري لمعدلات الدم لكل من البروتين، الالبيومين، ±: تم أخذ المتوسط الحسابي النتائجالضوئي. 
)، و التي TSA)، ناقلة امين الاسباراتات (TLAن الالانين()،ناقلة اميPLAالبيليروبين الكلي،الفوسفاتاز القلوي (
ملجم/دسل، 51.0±66.0جم/ل، 73.3±11.4جم/ل،  41.9±36.6كانت في مصل دم المدخنين بالترتيب كالآتي (
وحدة دولية / لتر)، و كانت 34.71 ± 48.751وحدة دولية / لتر، 98.8 ±91وحدة دولية / لتر،  64.8±66.62
ملجم/دسل،  61.0±55.0جم/ل،  87.2 ± 54.3جم/ل،  12.6±9.6مدخنين كالآتي (في مصل دم غير ال
وحدة دولية / لتر). كان هناك  25.11±76.641وحدة دولية / لتر،33.5±19.31وحدة دولية / لتر،  59.4±5.32
 صومستويات البيليروبين الكلية بين المدخنين والأشخا TLA، PLA) بين 50.0< Pفرق ذو دلالة إحصائية (
، 783.0=rعلى التوالي ( PLAو  TLAالغير مدخنين.كان للسن علاقة إيجابية مع مصل الدم لكل من البيليروبين، 
: كان في دم مدخني السجائر زيادة كبيرة الخلاصة). 520.0=p، 8130.0=r، 500.0=P، 393.0=r، 600.0=p
دراسة أيضا وجود علاقة إيجابية بين ومستوى البيليروبين الكلي. كما كشفت هذه ال TLAو  PLAفي مستويات 
 .PLAو  TLAالعمر و البيليروبين الكلي ، 
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Introduction 
Cigarette smoking is prevalent worldwide and it has been reported that approximately 
1/3 of the adult population smokes tobacco (1). The smoke of tobacco contains numerous 
harmful chemicals, including, but not limited to, carbon monoxide, nicotine, nitrogen 
oxides and cadmium (2). The deleterious sequelae of tobacco use are well recognized 
and the inherent health benefits of smoking cessation cannot be overstated. According 
to the World Health Organization, cigarette smoking was responsible for the death of 
100 million people worldwide in the 20th century. And it remains a major public health 
problem in the 21st century (3). Exposure of tobacco smoke has been considered as an 
important cause of preventable death worldwide (4). Numerous studies have examined 
the relationships between cigarette smoking and lifestyle-related diseases, including 
type 2 diabetes, dyslipidaemia, hypertension, and cardiovascular disease. These 
studies’ findings have demonstrated that these pathological conditions are negatively 
affected by cigarette smoking (5). There is a growing direct evidence for the relation 
between exposure to mainstream and side stream smoke and diseases resulting from 
reactive oxidant challenge and inflammation as a consequence of the combined activity 
of neutrophils, macrophages, dendritic cells, eosinophils, basophils, as a humoral 
immunological consequence of sensitization (6). Although the respiratory tract is the 
first target of cigarette smoke inhalation and cigarette smoking is a major risk factor for 
diseases of the airways such as chronic obstructive pulmonary disease, cigarette 
smoking causes a variety of adverse effects on organs that have no direct contact with 
the smoke itself such as liver, but very few studies take into consideration the effects of 
smoking in organs other than the respiratory system (7). The liver is an important organ 
that has many tasks; such as responsibility for processing drugs, alcohol and other 
toxins to eliminate them from the body (7, 8). Cigarette smoke contains a large number 
of chemical substances with hepatotoxic potential including nicotine (9). Basic and 
clinical research suggests that cigarette smoking affects the liver with numerous toxins 
in cigarettes altering enzymatic and inflammatory pathways in hepatic physiology (10). 
Although smoking is not considered a causative agent for chronic liver disease, there is 
increasing evidence that smoking may negatively impact the incidence, severity, and 
clinical course of many types of chronic liver diseases, including the development of 
hepatocellular carcinoma (11). Longitudinal studies, demonstrated that cigarette 
smoking was a significant risk factor associated with the onset of fatty liver disease in 
individuals who did not consume alcohol, and that this significant association persisted 
after adjusting for the potential confounders. Moreover, the incidence of fatty liver 
disease in the nondrinker group increased significantly as the number of cigarettes 
smoked increased (12). Laboratory liver tests are broadly defined as tests useful in the 
evaluation and treatment of patients with hepatic dysfunction. Some of the enzymes 
and the end products of the metabolic pathway which are very sensitive for the 
abnormality occurred may be considered as biochemical markers of liver dysfunction 
(13). Few studies in literature were concerned with the effects of smoking in the liver 
and the present study was a trial to shed light to reveal the effects. The study was built 
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on changes of metabolites and enzymes that reflect the activities of liver. Also in the 
present study some laboratory function tests were assessed for a group of heavy 
smokers, compared to a matching group of non smokers to clarify the toxic effects of 
smoking on liver. The objective of this study was to investigate the serum liver 
functions tests among Sudanese adult cigarette smokers. 
Materials and Methods: 
Reagents: All chemical reagents were purchased from Bios stem Company (Spain 
Company for Analytical Material and Chemical Reagents). 
Study population and data collection: This study was an analytical case control study, 
carried out in Omdurman city, 100 subjects enrolled in the study matched for age and 
sex, 50 cigarette smokers as case group, with their age ranged between 18 to 43 years 
with a mean age 24 years, and also 50 non smokers as control group, Number of 
cigarettes/day ranged between 5-20 cigarettes.  The study period from April to July 
2019. Questionnaires data including age, smoker history, chronic disease, and number 
of cigarettes consumed per day. Five ml of blood were collected in a plain container 
from each case and control. The blood was centrifuged at 5000 r.p.m. for 10 minutes to 
separate serum. Levels of liver function tests in the serum sample obtained were 
estimated by conventional methods using spectrophotometer. 
Inclusion and Exclusion Criteria: 
The criteria of inclusion were conserved of the smokers with heavy smoking, non 
alcohol users and freedom from chronic diseases. The exclusion criteria consisted of 
those smoking was taken fewer than  5 cigarettes/ day or those of non continuous use.  
Ethical Approval: 
We obtained ethical approval to carry this study from the ethical committee of Faculty 
of Medical Laboratory Sciences, Omdurman Islamic university, Omdurman, Sudan.  
Statistical analysis: All the results were analyzed by statistical analysis, using (SPSS) 
software (version16). t- test was used, and (P<0.05) value was considered significant.   
Results: 
The age of the study population and control were matched and ranged between (18-43 
years) with their mean 24.20±4.63. Number of cigarettes/day ranged between 5-20 
cigarettes. The (mean ± SD ) serum total protein, albumin, total Bilirubin, AST, ALT 
and ALP levels in smokers and non smokers   respectively were  (6.63±9.14 g/L, 
3.37±4.11 g/L, 0.66±0.15 mg/dL, 26.66±8.46 IU/L, 19.00±8.89 IU/L, 157.84±17.43 
IU/L) , (6.90±6.21 g/L, 3.45±2.78 g/L, 0.55±0.16 mg/dL, 23.50±4.95 IU/L, 13.91±5.33 
IU/L, 146.67±11.52 IU/L), respectively. While There was statistically significant 
differences (P<0.05) in serum ALP, ALT and total bilirubin levels between smokers 
and control subjects, and the data are presented in table (1). The age show a positive 
correlation with serum biluribin, serum ALT and serum ALP respectively (r=0.387, 
p=0.006), (r=0.393, P=0.005) (r=0.0318, p=0.025), are presented in figure (1, 2 and 3).  
 
 
EDITORIAL  
 
Gezira Journal Of Health Sciences vol.15(1) 20 91   
 
Gezira Journal Of Health Sciences vol.15(1) 2019 
Table (1): Serum liver function tests among study populations (n, 100) 
 
 
 
 
 
 
 
Figure (1): Positive correlation between age and serum total Bilirubin in cigarette 
smokers (n, 50) 
 
 
 
Parameters Smokers (Mean±SD) 
N= 50 
Non Smokers 
(Mean±SD) 
N= 50 
P-
value 
Total Protein 
(g/L) 
6. 63±9.14 mg/dL 6.90±6.21 mg/dL 0.158 
Albumin (g/L) 3.37±4.11 mg/dL 3.45±2.78 mg/dL 0.382 
Total Bilirubin  
(mg/dL) 
0.66±0.15 mg/dL 0.55±0.16 mg/dL 0.003 
AST (IU/L) 26.66±8.46 IU/L 23.50±4.95 IU/L 0.067 
ALT (IU/L) 19.00±8.89 IU/L 13.91±5.33 IU/L 0.006 
ALP (IU/L) 157.84±17.43 IU/L 146.67±11.52 IU/L 0.003 
AST/ALT 1.60±0.79 IU/L 1.71±0.45 IU/L 0.488 
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Figure (2): Positive correlation between age and serum ALT in cigarette smokers 
(n, 50) 
 
 
 
 
Figure (3): Positive correlation between age and serum ALP in cigarette smokers 
(n, 50) 
Discussion: 
Afew population studies have examined the relationship between smoking and enzymes 
measuring liver functions such as gamma-glutamyl transferase (GGT), alanine 
aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase 
(ALP) (14). In the present study the level of serum total protein in smokers was found 
less than the level in non smokers, although the difference was insignificant 
(P>0.05).The serum albumin was also found insignificantly decreased. This agrees with 
the findings of Eun Sun Jang et al as they reported cigarette smoking diminished serum 
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total protein and albumin (15). Serum total protein and albumin were significantly lower 
in heavy smokers compared to non smokers. Azzalini L, et al (16) reported significantly 
low level of total serum protein, and serum albumin in heavy smokers compared to non 
smokers. In the present study serum AST was insignificantly increased, while there is 
a significant increase in serum ALT. It was controversial whether smoking could affect 
aminotransferase activities. Some investigators claimed ALT was increased by 
smoking (17) while other studies argued that smoking did not influence AST or ALT, (18) 
Eun Sun Jang et al found significant increase in the level of alanine transaminase (ALT) 
and aspartate aminotransferase(AST) activities in heavy smokers compared to non 
smokers (15). Azzalini L et al (16) reported a statistically significant elevations in serum 
alanine transaminase (ALT) and aspartate aminotransferase (AST) activities in heavy 
smokers compared to non smokers. Studying the effects of smoking on liver S Goya, 
and Gerald Shaper reported increased level of AST. Sangar Najat Abdul-Razaq, 
Bakhtiar M. Ahmed found high level of in serum alanine transaminase (ALT) and 
aspartate aminotransferase(AST) activities in heavy smokers compared to non smokers 
(20).In the present study the level of ALP was found significantly highly ,that matches 
the findings of Sangar Najat Abdul-Razaq ,and Bakhtiar M. Ahmed .Their results 
showed that serum ALP was significantly high (P value<0.05) in heavy smoker group 
when compared with non smokers group(20). Goya, and Gerald Shaper found that 
cigarette smoking was significantly associated with increased levels of ALP (P < 
0.0001. Hie-Won Hann, et al observed an increase in ALP level amongst heavy 
smokers. (21).This study revealed significant increase in serum total bilirubin levels 
between smokers and control subjects which may be a result of smoke toxic effects on 
liver. It was fairly established that smoking increases the production of pro-
inflammatory cytokines (IL-1, IL-6 and TNF-α) involved in liver cell injury (22). Our 
study recommended that, the cigarette smoker needs to assess the liver function test 
routinely. 
Conclusion  
Cigarette smokers had a significant increase in serum ALP, ALT and total bilirubin 
levels. This study also revealed a positive correlation between age and serum total 
bilirubin, ALT and ALP. 
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